FDA Advisory Panel Decision on Avandia Looms

FRIDAY, July 9 (HealthDay News) -- With a crucial recommendation on the fate of the controversial diabetes drug Avandia due next week, U.S. health officials seem to be gearing up for tough scrutiny over the drug's future.